Biotechnology Trading Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotechnology trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotechnology Trading Down Today - Breaking & Trending Today

Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $110.00 price objective on the stock. A number of other research firms have also weighed in on VIR. JPMorgan Chase & Co. boosted their target price on […] ....

Annm Hanly , Hermes Inc , Fifth Third Bancorp , Needham Company , Jpmorgan Chase Co , Third Bancorp , Vir Biotechnology Inc , Quadrant Capital Group , Securities Exchange Commission , Vir Biotechnology , Free Report , Moderate Buy , Biotechnology Trading Down , Get Free Report , Exchange Commission , Capital Group , Federated Hermes , Vir Biotechnology Daily ,

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Position Lessened by Vanguard Capital Wealth Advisors

Vanguard Capital Wealth Advisors decreased its stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 13.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 6,000 shares during the period. Vanguard Capital […] ....

Sujalm Patel , Presidio Capital Management , Exchange Commission , Securities Exchange Commission , Kestra Private Wealth Services , China Universal Asset Management Co , Nautilus Biotechnology Company Profile , Sg Americas Securities , Hermes Inc , Nautilus Biotechnology Inc , Vanguard Capital Wealth Advisors , Nautilus Biotechnology , Free Report , Capital Wealth Advisor , Capital Management , Private Wealth Services , Universal Asset Management , Biotechnology Trading Down , Get Free Report , Nautilus Platform , Nautilus Biotechnology Daily , Nasdaq Naut , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 3.8%

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 3.8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Robert Nelsen , York State Common Retirement Fund , Sana Biotechnology Inc , Securities Exchange Commission , Swiss National Bank , Sana Biotechnology Company Profile , American International Group Inc , Principal Financial Group Inc , Manufacturers Life Insurance Company , Sana Biotechnology , Get Free Report , Biotechnology Trading Down , Director Robert Nelsen , Exchange Commission , International Group , Financial Group , National Bank , Sana Biotechnology Daily ,

StockNews.com Lowers Puma Biotechnology (NASDAQ:PBYI) to Hold

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reduced their target price on Puma Biotechnology from $8.00 to $7.00 and set a “buy” rating on the stock in a research report […] ....

United States , Puma Biotechnology Company Profile , Goldman Sachs Group Inc , Great Point Partners , Puma Biotechnology Inc , Sei Investments Co , Vanguard Group Inc , Puma Biotechnology , Get Free Report , Biotechnology Trading Down , Sachs Group , Point Partners , Sei Investments , Puma Biotechnology Daily , Nasdaq Pbyi , Stocknews Com ,

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells 72,995 Shares of Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total value of $690,532.70. Following the sale, the chief executive officer now directly owns 678,457 […] ....

Quadrant Capital Group , Jpmorgan Chase Co , Third Bancorp , Fifth Third Bancorp , Vir Biotechnology Inc , China Universal Asset Management Co , Vir Biotechnology , Get Free Report , Biotechnology Trading Down , Capital Group , Universal Asset Management , Captrust Financial Advisors , Financial Advisors , Vir Biotechnology Daily , Nasdaq Vir , Insider Trading , Nsider Trades ,